NASDAQ:PLRZ Polyrizon Q4 2025 Earnings Report $12.75 +1.27 (+11.06%) Closing price 04:00 PM EasternExtended Trading$12.13 -0.62 (-4.89%) As of 07:40 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. ProfileEarnings HistoryForecast Polyrizon EPS ResultsActual EPS-$2.81Consensus EPS N/ABeat/MissN/AOne Year Ago EPSN/APolyrizon Revenue ResultsActual RevenueN/AExpected RevenueN/ABeat/MissN/AYoY Revenue GrowthN/APolyrizon Announcement DetailsQuarterQ4 2025Date2/14/2026TimeAfter Market ClosesConference Call DateN/AConference Call TimeN/AConference Call ResourcesEarnings HistoryCompany Profile Polyrizon Earnings HeadlinesPolyrizon Wins Central IRB Nod for First NASARIX Allergy Blocker TrialJune 29 at 4:31 PM | tipranks.comPolyrizon Receives Central IRB Approval for First Human Clinical Trial of NASARIX Allergy BlockerJune 29 at 9:11 AM | quiverquant.comQYour book attachedBill Poulos is giving away his 'Safe Trade Options Formula' book for free - but only for a limited time through a temporary download link. He plans to charge for it soon. Download your copy now and lock it in at no cost, regardless of future pricing.June 29 at 1:00 AM | Profits Run (Ad)Polyrizon Makes Strong Progress: Receives Central IRB Approval for its Allergy Blocker Clinical TrialJune 29 at 8:44 AM | globenewswire.comPolyrizon Announces U.S. Publication of Mucoadhesive Nasal Drug Delivery PatentJune 17, 2026 | tipranks.comPolyrizon Ltd.: Polyrizon Receives Notice of U.S. Patent Publication for Mucoadhesive Drug Delivery PlatformJune 17, 2026 | finanznachrichten.deSee More Polyrizon Headlines Get Earnings Announcements in your inboxWant to stay updated on the latest earnings announcements and upcoming reports for companies like Polyrizon? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Polyrizon and other key companies, straight to your email. Email Address About PolyrizonPolyrizon (NASDAQ:PLRZ) is a development stage biotech company specializing in the development of medical device hydrogels delivered in the form of nasal sprays. Polyrizon Ltd. is based in Raanana, Israel.View Polyrizon ProfileRead more More Earnings Resources from MarketBeat Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Latest Articles Winnebago Misses Estimates, But Surges 14% After EarningsBlackBerry’s Rally Is Running on a Bigger AI Story Than Earnings AloneTrip.com’s Selloff Raises a Bigger Question About Its Travel Recovery StoryFabrinet Is Becoming a Quiet Winner in the AI Optics BuildoutIs McCormick a Steal Ahead of Game-Changing Unilever Deal?New Stock Price Highs Are on the Menu for Darden RestaurantsMicron’s HBM Surge Could Redefine the AI Growth Story Upcoming Earnings NIKE (6/30/2026)PepsiCo (7/9/2026)Delta Air Lines (7/9/2026)Bank of America (7/14/2026)The Goldman Sachs Group (7/14/2026)JPMorgan Chase & Co. (7/14/2026)Wells Fargo & Company (7/14/2026)Citigroup (7/14/2026)Fastenal (7/14/2026)ASML (7/15/2026) Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
